Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Sibold William John
President and CEO at MADRIGAL PHARMACEUTICALS. Filing since 9 Sep 2024.
CIK 0001518611
Company
Date
Role
Action
Shares
Amount
Of holding
MDGL
MADRIGAL PHARMACEUTICALS, INC.
11 Sep 2026
President and CEO
Sold on a plan
5,221
$2.83M
2.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
9 Sep 2026
President and CEO
Sold on a plan
6,362
$3.41M
3.0%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
20 Jul 2026
President and CEO
Sold at will
2,500
$1.37M
1.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
6 Mar 2026
President and CEO
Sold at will
1,663
$718.32K
1.0%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
26 Jan 2026
President and CEO
Sold at will
1,577
$776.55K
1.1%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
4 Dec 2025
President and CEO
Sold at will
2,400
$1.38M
1.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
9 Sep 2025
President and CEO
Sold at will
7,279
$3.24M
6.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
21 Aug 2025
President and CEO
Sold on a plan
7,616
$3.05M
6.5%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
24 Jan 2025
President and CEO
Sold at will
1,584
$531.02K
2.8%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
9 Sep 2024
President and CEO
Sold at will
6,363
$1.55M
10.2%
10 decisions on file.
